Barely Significant
← all excerpts

Current and Emerging Therapies to Combat Cystic Fibrosis Lung Infections.

Microorganisms · 2021 · PMC8466233 · PMID 34576767

Europe PMCDOI
1
hedged sentence
0.0520
closest p · 1.0× alpha
0.0520
boldest claim

The sentences

borderline significantp = 0.052so close (0.05 < p ≤ 0.1)
Respiratory infections in the treatment (non-placebo) cohorts of the STRIVE ENVISION groups rose significantly from 21% of the treatment group at the start of PERSIST to 29% after 144 weeks of treatment ( p = 0.039—by paired χ 2 test of proportions in a single sample) while pulmonary exacerbations rose at the same timepoints from 38% to 46% (borderline significant: p = 0.052).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.